Serum Institute of India controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2020
Vaccine trial participant sues Serum Institute of India
Lawsuit filed
A participant in the Covishield vaccine trial sued Serum Institute of India, claiming that he suffered serious neurological impairment after receiving the experimental vaccine. He sought Rs 5 crore in compensation. The reported account does not establish that the claimed causal link was determined.
Company response
Denial — Serum Institute of India
The allegations in the notice are malicious and misconceived. While the Serum Institute of India is sympathetic with the volunteer's medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer.
Denial — Serum Institute of India
The firm has also said the man's illness had nothing to do with the vaccine trials.
Source excerpt
The man has sought Rs 5 crore as compensation.
A 40-year-old Chennai-based participant in the trial for the Covishield vaccine developed by the Pune-based Serum Institute of India has sued the company, claiming he has suffered serious neurological impairment after the under-trial coronavirus vaccine was administered to him, PTI reported on Sunday.
A 40-year-old volunteer for 'Covishield', the candidate vaccine being tested by the Pune-based Serum Institute of India (SII), has sued the company for ₹5 crore, alleging that the vaccine triggered an adverse reaction, which includes neurological impairment and an inability to get back to the life before being inoculated.